Showing results (451-460 of 944) with videos related to
Sort By:
Pageof 95
Journal of Child Psychology and Psychiatry, and Allied Disciplines|June 6, 2022
Perceived sleep quality predicts aggressive offending in adolescence and young adulthoodColleen Brown, Jordan Beardslee, Paul J Frick, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1985
Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoproteinS Parthasarathy, U P Steinbrecher, J Barnett, et al.European Journal of Immunology|August 1, 1986
Effect of anti-Ia treatment on the production of anti-DNA antibody by NZB miceD M Klinman, M D Lefkowitz, E S Raveche, et al.The Journal of Experimental Medicine|April 1, 1982
Studies of defective tolerance induction in NZB mice. Evidence for a marrow pre-T cell defectC A Laskin, P A Smathers, J P Reeves, et al.International Archives of Allergy and Applied Immunology|January 1, 1982
Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjögren's syndrome and rheumatoid arthritisJ Karsh, S P Halbert, M Anken, et al.BJU International|November 16, 2004
Neobladder-vaginal fistula after cystectomy and orthotopic neobladder constructionDavid E Rapp, R Corey O'connor, Erin E Katz, et al.Thyroid : Official Journal of the American Thyroid Association|January 11, 1991
Thyroid stimulating and thyrotrophin binding-inhibitory immunoglobulin activity in patients with systemic lupus erythematosus having thyroid function abnormalitiesJ R Baker, F W Miller, A D Steinberg, et al.The Canadian Journal of Urology|September 25, 2003
Primary amyloidosis of the bladder treated with partial cystectomyNejd F Alsikafi, R Corey O'Connor, Ximing J Yang, et al.Expert Opinion on Pharmacotherapy|October 5, 2001
Intravesical valrubicin in the treatment of carcinoma in situ of the bladderD D Kuznetsov, N F Alsikafi, R C O'Connor, et al.Journal of Lipid Research|August 24, 2001
Scavenger receptor class B type I as a receptor for oxidized low density lipoproteinK Gillotte-Taylor, A Boullier, J L Witztum, et al.Pageof 95